Sino-Agri Leading Biosciences Co Ltd
SSE:603970
Sino-Agri Leading Biosciences Co Ltd
SSE:603970
Price:
12.57
CNY
Market Cap:
¥3.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Sino-Agri Leading Biosciences Co Ltd
SSE:603970
|
CN |
|
DMG Mori AG
XETRA:GIL
|
DE |
|
Lagnam Spintex Ltd
NSE:LAGNAM
|
IN |
|
Chongqing Fuling Zhacai Group Co Ltd
SZSE:002507
|
CN |
|
Kier Group PLC
LSE:KIE
|
UK |
Income Statement
Earnings Waterfall
Sino-Agri Leading Biosciences Co Ltd
Sino-Agri Leading Biosciences Co Ltd
Income Statement
Sino-Agri Leading Biosciences Co Ltd
Sino-Agri Leading Biosciences Co Ltd
Currency: CNY
| Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
28
|
9
|
0
|
20
|
15
|
31
|
45
|
44
|
46
|
46
|
42
|
45
|
45
|
42
|
39
|
36
|
34
|
33
|
33
|
29
|
27
|
26
|
21
|
21
|
16
|
18
|
21
|
21
|
22
|
21
|
0
|
0
|
|
| Revenue |
3 489
N/A
|
3 504
+0%
|
3 629
+4%
|
3 573
-2%
|
3 561
0%
|
3 735
+5%
|
3 850
+3%
|
4 015
+4%
|
4 195
+4%
|
4 343
+4%
|
4 521
+4%
|
5 260
+16%
|
6 120
+16%
|
6 641
+9%
|
7 102
+7%
|
7 978
+12%
|
8 933
+12%
|
8 822
-1%
|
9 036
+2%
|
10 039
+11%
|
11 032
+10%
|
11 699
+6%
|
12 007
+3%
|
11 890
-1%
|
10 380
-13%
|
10 460
+1%
|
10 514
+1%
|
10 706
+2%
|
10 610
-1%
|
10 596
0%
|
10 730
+1%
|
10 809
+1%
|
11 031
+2%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(3 086)
|
(3 095)
|
(3 209)
|
(3 167)
|
(3 146)
|
(3 325)
|
(3 432)
|
(3 571)
|
(3 749)
|
(3 901)
|
(4 077)
|
(4 778)
|
(5 615)
|
(6 126)
|
(6 553)
|
(7 447)
|
(8 399)
|
(8 292)
|
(8 477)
|
(9 398)
|
(10 301)
|
(10 972)
|
(11 221)
|
(11 121)
|
(9 673)
|
(9 758)
|
(9 748)
|
(9 917)
|
(9 827)
|
(9 878)
|
(9 995)
|
(10 076)
|
(10 286)
|
|
| Gross Profit |
402
N/A
|
409
+2%
|
419
+3%
|
407
-3%
|
415
+2%
|
410
-1%
|
418
+2%
|
444
+6%
|
447
+1%
|
441
-1%
|
444
+1%
|
481
+8%
|
505
+5%
|
516
+2%
|
548
+6%
|
531
-3%
|
534
+1%
|
530
-1%
|
559
+5%
|
641
+15%
|
731
+14%
|
727
-1%
|
787
+8%
|
769
-2%
|
707
-8%
|
702
-1%
|
766
+9%
|
789
+3%
|
783
-1%
|
718
-8%
|
736
+2%
|
733
0%
|
745
+2%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||
| Operating Expenses |
(259)
|
(268)
|
(262)
|
(253)
|
(266)
|
(246)
|
(249)
|
(253)
|
(253)
|
(259)
|
(251)
|
(268)
|
(273)
|
(277)
|
(295)
|
(309)
|
(319)
|
(298)
|
(349)
|
(348)
|
(350)
|
(370)
|
(394)
|
(409)
|
(422)
|
(406)
|
(453)
|
(452)
|
(467)
|
(413)
|
(433)
|
(444)
|
(443)
|
|
| Selling, General & Administrative |
(262)
|
(249)
|
(275)
|
(266)
|
(260)
|
(220)
|
(233)
|
(229)
|
(227)
|
(215)
|
(218)
|
(233)
|
(239)
|
(232)
|
(248)
|
(242)
|
(247)
|
(244)
|
(263)
|
(285)
|
(288)
|
(299)
|
(314)
|
(314)
|
(323)
|
(322)
|
(324)
|
(327)
|
(331)
|
(322)
|
(354)
|
(348)
|
(362)
|
|
| Research & Development |
0
|
(2)
|
0
|
0
|
0
|
(13)
|
(13)
|
(20)
|
(23)
|
(31)
|
(33)
|
(31)
|
(31)
|
(34)
|
(36)
|
(37)
|
(40)
|
(35)
|
(37)
|
(38)
|
(39)
|
(44)
|
(48)
|
(60)
|
(68)
|
(63)
|
(72)
|
(66)
|
(71)
|
(65)
|
(67)
|
(69)
|
(66)
|
|
| Depreciation & Amortization |
0
|
(23)
|
0
|
0
|
0
|
(19)
|
0
|
0
|
0
|
(12)
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(19)
|
0
|
0
|
0
|
(23)
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
3
|
7
|
13
|
14
|
(6)
|
6
|
(3)
|
(4)
|
(3)
|
(1)
|
1
|
(4)
|
(4)
|
0
|
(11)
|
(31)
|
(32)
|
0
|
(49)
|
(24)
|
(23)
|
(5)
|
(33)
|
(35)
|
(31)
|
1
|
(57)
|
(58)
|
(66)
|
(5)
|
(12)
|
(28)
|
(15)
|
|
| Operating Income |
144
N/A
|
141
-2%
|
158
+12%
|
154
-2%
|
150
-3%
|
163
+9%
|
169
+4%
|
191
+13%
|
193
+1%
|
182
-6%
|
193
+6%
|
213
+11%
|
232
+9%
|
239
+3%
|
254
+6%
|
222
-12%
|
215
-3%
|
233
+8%
|
210
-10%
|
293
+40%
|
380
+30%
|
357
-6%
|
392
+10%
|
360
-8%
|
285
-21%
|
295
+4%
|
313
+6%
|
338
+8%
|
315
-7%
|
305
-3%
|
302
-1%
|
288
-5%
|
302
+5%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(31)
|
(34)
|
(29)
|
(20)
|
(13)
|
(11)
|
(4)
|
(30)
|
(29)
|
(40)
|
(37)
|
(39)
|
(54)
|
(26)
|
(33)
|
19
|
42
|
4
|
37
|
(21)
|
(73)
|
(32)
|
(50)
|
(21)
|
22
|
20
|
1
|
(17)
|
(11)
|
(3)
|
(10)
|
(10)
|
(29)
|
|
| Non-Reccuring Items |
0
|
15
|
0
|
0
|
12
|
3
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
(2)
|
0
|
1
|
1
|
2
|
0
|
(0)
|
(1)
|
(0)
|
(1)
|
0
|
1
|
0
|
1
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
| Total Other Income |
11
|
1
|
(0)
|
2
|
(2)
|
2
|
1
|
7
|
7
|
8
|
8
|
2
|
2
|
(4)
|
(4)
|
(4)
|
(4)
|
1
|
1
|
1
|
0
|
1
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Pre-Tax Income |
124
N/A
|
124
+0%
|
128
+3%
|
135
+6%
|
147
+8%
|
158
+8%
|
167
+5%
|
169
+1%
|
171
+1%
|
156
-9%
|
163
+5%
|
177
+8%
|
180
+2%
|
208
+15%
|
217
+4%
|
237
+10%
|
253
+7%
|
240
-5%
|
249
+4%
|
272
+9%
|
307
+13%
|
326
+6%
|
341
+5%
|
339
-1%
|
307
-9%
|
315
+3%
|
315
+0%
|
321
+2%
|
304
-5%
|
302
-1%
|
293
-3%
|
278
-5%
|
273
-2%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||
| Tax Provision |
(33)
|
(34)
|
(35)
|
(36)
|
(43)
|
(43)
|
(45)
|
(40)
|
(40)
|
(31)
|
(32)
|
(36)
|
(36)
|
(52)
|
(56)
|
(60)
|
(61)
|
(55)
|
(55)
|
(60)
|
(72)
|
(78)
|
(86)
|
(80)
|
(67)
|
(68)
|
(64)
|
(71)
|
(71)
|
(73)
|
(68)
|
(63)
|
(61)
|
|
| Income from Continuing Operations |
90
|
90
|
93
|
99
|
104
|
115
|
122
|
128
|
132
|
125
|
132
|
141
|
143
|
155
|
161
|
177
|
192
|
186
|
194
|
212
|
235
|
248
|
256
|
259
|
239
|
248
|
251
|
250
|
233
|
229
|
225
|
216
|
212
|
|
| Income to Minority Interest |
(2)
|
1
|
3
|
8
|
5
|
0
|
(1)
|
(7)
|
(11)
|
(6)
|
(12)
|
(16)
|
(13)
|
(23)
|
(22)
|
(26)
|
(30)
|
(15)
|
(14)
|
(15)
|
(32)
|
(38)
|
(36)
|
(35)
|
(17)
|
(23)
|
(23)
|
(20)
|
(15)
|
(25)
|
(24)
|
(28)
|
(32)
|
|
| Net Income (Common) |
88
N/A
|
90
+2%
|
96
+7%
|
106
+10%
|
109
+2%
|
116
+6%
|
120
+4%
|
121
+1%
|
121
0%
|
119
-2%
|
120
+1%
|
125
+5%
|
130
+4%
|
132
+2%
|
138
+4%
|
151
+10%
|
162
+7%
|
170
+5%
|
180
+6%
|
197
+10%
|
203
+3%
|
210
+4%
|
219
+4%
|
224
+2%
|
223
0%
|
225
+1%
|
228
+1%
|
231
+1%
|
218
-5%
|
203
-7%
|
200
-1%
|
187
-6%
|
180
-4%
|
|
| EPS (Diluted) |
0.62
N/A
|
0.61
-2%
|
0.5
-18%
|
0.55
+10%
|
0.58
+5%
|
0.6
+3%
|
0.63
+5%
|
0.63
N/A
|
0.63
N/A
|
0.62
-2%
|
0.62
N/A
|
0.65
+5%
|
0.68
+5%
|
0.69
+1%
|
0.72
+4%
|
0.79
+10%
|
0.84
+6%
|
0.63
-25%
|
0.94
+49%
|
1.03
+10%
|
0.75
-27%
|
0.78
+4%
|
0.81
+4%
|
0.83
+2%
|
0.83
N/A
|
0.84
+1%
|
0.85
+1%
|
0.86
+1%
|
0.81
-6%
|
0.76
-6%
|
0.75
-1%
|
0.7
-7%
|
0.67
-4%
|
|
Switch to:
Switch to:
See Also
Discover More
